Skip to main content

Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 52 Accesses

Definition

A high-grade carcinoma with variable architectural pattern in the same tumor, often with prominent nucleoli and perinucleolar clearing and demonstrating germline mutations in the gene encoding fumarate hydratase (FH).

Clinical Features

Patients may present with cutaneous and/or uterine leiomyomas (Reedā€™s syndrome) (Patel et al. 2017). Cases with somatic and not germline mutation in FH gene has been reported.

  • Incidence

    It is a rare tumor, comprising <1% of all resected tumors.

  • Age

    The mean age is around 40 years.

  • Sex

    No sex predilection has been noted.

  • Site

    There is no site predilection.

  • Treatment

    Radical nephrectomy.

  • Outcome

    The prognosis of patients with hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma is poor with tendency to early widespread dissemination.

Macroscopy

Unlike most hereditary renal cell carcinomas involving the kidneys, hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma may present as a single...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

  • Muller, M., Guillaud-Bataille, M., Salleron, J., et al. (2018). Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Modern Pathology, 31, 974ā€“983.

    ArticleĀ  CASĀ  Google ScholarĀ 

  • Ohe, C., Smith, S. C., Sirohi, D., et al. (2018). Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma. The American Journal of Surgical Pathology, 42, 279ā€“292.

    ArticleĀ  Google ScholarĀ 

  • Patel, V. M., Handler, M. Z., Schwartz, R. A., & Lambert, W. C. (2017). Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review. Journal of the American Academy of Dermatology, 77, 149ā€“158.

    ArticleĀ  Google ScholarĀ 

  • Smith, S. C., Trpkov, K., Chen, Y. B., et al. (2016). Tubulocystic carcinoma of the kidney with poorly differentiated foci: A frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. The American Journal of Surgical Pathology, 40, 1457ā€“1472.

    ArticleĀ  Google ScholarĀ 

  • Smith, S. C., Sirohi, D., Ohe, C., et al. (2017). A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology, 71, 42ā€“52.

    ArticleĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guido Martignoni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

CaliĆ², A., Segala, D., Martignoni, G. (2019). Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4825-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_4825-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics